-
1
-
-
79551681501
-
Health care and equity in India
-
Balarajan, Y., Selvaraj, S. & Subramanian, S.V. (2011) Health care and equity in India. Lancet, 377, 505-515.
-
(2011)
Lancet
, vol.377
, pp. 505-515
-
-
Balarajan, Y.1
Selvaraj, S.2
Subramanian, S.V.3
-
2
-
-
84875604950
-
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole
-
Barreto, J.N., Beach, C.L., Wolf, R.C., Merten, J.A., Tosh, P.K., Wilson, J.W., Hogan, W.J. & Litzow, M.R. (2013) The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole. American Journal of Hematology, 88, 283-288.
-
(2013)
American Journal of Hematology
, vol.88
, pp. 283-288
-
-
Barreto, J.N.1
Beach, C.L.2
Wolf, R.C.3
Merten, J.A.4
Tosh, P.K.5
Wilson, J.W.6
Hogan, W.J.7
Litzow, M.R.8
-
3
-
-
0017162163
-
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
-
Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. British Journal of Haematology, 33, 451-458.
-
(1976)
British Journal of Haematology
, vol.33
, pp. 451-458
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.5
Gralnick, H.R.6
Sultan, C.7
-
4
-
-
77449149374
-
Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia
-
Cashen, A.F., Schiller, G.J., O'Donnell, M.R. & DiPersio, J.F. (2010) Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. Journal of Clinical Oncology, 28, 556-561.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 556-561
-
-
Cashen, A.F.1
Schiller, G.J.2
O'Donnell, M.R.3
DiPersio, J.F.4
-
5
-
-
84859829132
-
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
-
Chendamarai, E., Balasubramanian, P., George, B., Viswabandya, A., Abraham, A., Ahmed, R., Alex, A.A., Ganesan, S., Lakshmi, K.M., Sitaram, U., Nair, S.C., Chandy, M., Janet, N.B., Srivastava, V.M., Srivastava, A. & Mathews, V. (2012) Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Blood, 119, 3413-3419.
-
(2012)
Blood
, vol.119
, pp. 3413-3419
-
-
Chendamarai, E.1
Balasubramanian, P.2
George, B.3
Viswabandya, A.4
Abraham, A.5
Ahmed, R.6
Alex, A.A.7
Ganesan, S.8
Lakshmi, K.M.9
Sitaram, U.10
Nair, S.C.11
Chandy, M.12
Janet, N.B.13
Srivastava, V.M.14
Srivastava, A.15
Mathews, V.16
-
6
-
-
1542753559
-
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
-
Cheson, B.D., Bennett, J.M., Kopecky, K.J., Buchner, T., Willman, C.L., Estey, E.H., Schiffer, C.A., Doehner, H., Tallman, M.S., Lister, T.A., Lo-Coco, F., Willemze, R., Biondi, A., Hiddemann, W., Larson, R.A., Lowenberg, B., Sanz, M.A., Head, D.R., Ohno, R. & Bloomfield, C.D. (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Journal of Clinical Oncology, 21, 4642-4649.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 4642-4649
-
-
Cheson, B.D.1
Bennett, J.M.2
Kopecky, K.J.3
Buchner, T.4
Willman, C.L.5
Estey, E.H.6
Schiffer, C.A.7
Doehner, H.8
Tallman, M.S.9
Lister, T.A.10
Lo-Coco, F.11
Willemze, R.12
Biondi, A.13
Hiddemann, W.14
Larson, R.A.15
Lowenberg, B.16
Sanz, M.A.17
Head, D.R.18
Ohno, R.19
Bloomfield, C.D.20
more..
-
7
-
-
84859378748
-
Underreporting of myeloid malignancies by United States cancer registries
-
Craig, B.M., Rollison, D.E., List, A.F. & Cogle, C.R. (2012) Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiology, Biomarkers & Prevention, 21, 474-481.
-
(2012)
Cancer Epidemiology, Biomarkers & Prevention
, vol.21
, pp. 474-481
-
-
Craig, B.M.1
Rollison, D.E.2
List, A.F.3
Cogle, C.R.4
-
8
-
-
33749041474
-
Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98
-
Creutzig, U., Zimmermann, M., Lehrnbecher, T., Graf, N., Hermann, J., Niemeyer, C.M., Reiter, A., Ritter, J.R., Dworzak, M. & Stary, J. (2006) Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Journal of Clinical Oncology, 24, 4499-4506.
-
(2006)
Journal of Clinical Oncology
, vol.24
, pp. 4499-4506
-
-
Creutzig, U.1
Zimmermann, M.2
Lehrnbecher, T.3
Graf, N.4
Hermann, J.5
Niemeyer, C.M.6
Reiter, A.7
Ritter, J.R.8
Dworzak, M.9
Stary, J.10
-
9
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
-
De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., Pappas, P.G., Maertens, J., Lortholary, O., Kauffman, C.A., Denning, D.W., Patterson, T.F., Maschmeyer, G., Bille, J., Dismukes, W.E., Herbrecht, R., Hope, W.W., Kibbler, C.C., Kullberg, B.J., Marr, K.A., Munoz, P., Odds, F.C., Perfect, J.R., Restrepo, A., Ruhnke, M., Segal, B.H., Sobel, J.D., Sorrell, T.C., Viscoli, C., Wingard, J.R., Zaoutis, T. & Bennett, J.E. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases, 46, 1813-1821.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 1813-1821
-
-
De Pauw, B.1
Walsh, T.J.2
Donnelly, J.P.3
Stevens, D.A.4
Edwards, J.E.5
Calandra, T.6
Pappas, P.G.7
Maertens, J.8
Lortholary, O.9
Kauffman, C.A.10
Denning, D.W.11
Patterson, T.F.12
Maschmeyer, G.13
Bille, J.14
Dismukes, W.E.15
Herbrecht, R.16
Hope, W.W.17
Kibbler, C.C.18
Kullberg, B.J.19
Marr, K.A.20
Munoz, P.21
Odds, F.C.22
Perfect, J.R.23
Restrepo, A.24
Ruhnke, M.25
Segal, B.H.26
Sobel, J.D.27
Sorrell, T.C.28
Viscoli, C.29
Wingard, J.R.30
Zaoutis, T.31
Bennett, J.E.32
more..
-
10
-
-
77449149373
-
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
-
Fenaux, P., Mufti, G.J., Hellstrom-Lindberg, E., Santini, V., Gattermann, N., Germing, U., Sanz, G., List, A.F., Gore, S., Seymour, J.F., Dombret, H., Backstrom, J., Zimmerman, L., McKenzie, D., Beach, C.L. & Silverman, L.R. (2009) Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. Journal of Clinical Oncology, 28, 562-569.
-
(2009)
Journal of Clinical Oncology
, vol.28
, pp. 562-569
-
-
Fenaux, P.1
Mufti, G.J.2
Hellstrom-Lindberg, E.3
Santini, V.4
Gattermann, N.5
Germing, U.6
Sanz, G.7
List, A.F.8
Gore, S.9
Seymour, J.F.10
Dombret, H.11
Backstrom, J.12
Zimmerman, L.13
McKenzie, D.14
Beach, C.L.15
Silverman, L.R.16
-
11
-
-
79951816939
-
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america
-
Freifeld, A.G., Bow, E.J., Sepkowitz, K.A., Boeckh, M.J., Ito, J.I., Mullen, C.A., Raad, II, Rolston, K.V., Young, J.A. & Wingard, J.R. for the Infectious Diseases Society of America. (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clinical Infectious Diseases, 52, e56-e93.
-
(2011)
Clinical Infectious Diseases
, vol.52
, pp. e56-e93
-
-
Freifeld, A.G.1
Bow, E.J.2
Sepkowitz, K.A.3
Boeckh, M.J.4
Ito, J.I.5
Mullen, C.A.6
Raad, I.I.7
Rolston, K.V.8
Young, J.A.9
Wingard, J.R.10
-
12
-
-
60249089704
-
Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India
-
Garg, C.C. & Karan, A.K. (2009) Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India. Health Policy Plan, 24, 116-128.
-
(2009)
Health Policy Plan
, vol.24
, pp. 116-128
-
-
Garg, C.C.1
Karan, A.K.2
-
13
-
-
84897107676
-
Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia
-
Girmenia, C., Micozzi, A., Piciocchi, A., Gentile, G., Di Caprio, L., Nasso, D., Minotti, C., Capria, S., Cartoni, C., Alimena, G., Meloni, G., Amadori, S., Foa, R. & Venditti, A. (2014) Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia. Leukemia Research, 38, 469-474.
-
(2014)
Leukemia Research
, vol.38
, pp. 469-474
-
-
Girmenia, C.1
Micozzi, A.2
Piciocchi, A.3
Gentile, G.4
Di Caprio, L.5
Nasso, D.6
Minotti, C.7
Capria, S.8
Cartoni, C.9
Alimena, G.10
Meloni, G.11
Amadori, S.12
Foa, R.13
Venditti, A.14
-
14
-
-
84893448431
-
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011
-
Gomes, M.Z., Mulanovich, V.E., Jiang, Y., Lewis, R.E. & Kontoyiannis, D.P. (2013) Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrobial Agents and Chemotherapy, 58, 865-873.
-
(2013)
Antimicrobial Agents and Chemotherapy
, vol.58
, pp. 865-873
-
-
Gomes, M.Z.1
Mulanovich, V.E.2
Jiang, Y.3
Lewis, R.E.4
Kontoyiannis, D.P.5
-
15
-
-
77955914238
-
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
-
Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., Wheatley, K., Harrison, C.J. & Burnett, A.K. (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116, 354-365.
-
(2010)
Blood
, vol.116
, pp. 354-365
-
-
Grimwade, D.1
Hills, R.K.2
Moorman, A.V.3
Walker, H.4
Chatters, S.5
Goldstone, A.H.6
Wheatley, K.7
Harrison, C.J.8
Burnett, A.K.9
-
16
-
-
78651450309
-
Indian health: the path from crisis to progress
-
Horton, R. & Das, P. (2011) Indian health: the path from crisis to progress. The Lancet, 377, 181-183.
-
(2011)
The Lancet
, vol.377
, pp. 181-183
-
-
Horton, R.1
Das, P.2
-
17
-
-
84875181975
-
Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance
-
Johnson, A.P. & Woodford, N. (2013) Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. Journal of Medical Microbiology, 62, 499-513.
-
(2013)
Journal of Medical Microbiology
, vol.62
, pp. 499-513
-
-
Johnson, A.P.1
Woodford, N.2
-
18
-
-
84860317991
-
Acute myeloid leukemia in the real world: why population-based registries are needed
-
Juliusson, G., Lazarevic, V., Horstedt, A.S., Hagberg, O. & Hoglund, M. (2012) Acute myeloid leukemia in the real world: why population-based registries are needed. Blood, 119, 3890-3899.
-
(2012)
Blood
, vol.119
, pp. 3890-3899
-
-
Juliusson, G.1
Lazarevic, V.2
Horstedt, A.S.3
Hagberg, O.4
Hoglund, M.5
-
19
-
-
84866269073
-
United States Centers For Disease control and prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae
-
20207.
-
Kallen, A. & Guh, A. (2012) United States Centers For Disease control and prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae. Eurosurveillance, 17, 20207.
-
(2012)
Eurosurveillance
, vol.17
-
-
Kallen, A.1
Guh, A.2
-
20
-
-
84872927118
-
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands
-
Leunis, A., Blommestein, H.M., Huijgens, P.C., Blijlevens, N.M., Jongen-Lavrencic, M. & Uyl-de Groot, C.A. (2012) The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leukemia Research, 37, 245-250.
-
(2012)
Leukemia Research
, vol.37
, pp. 245-250
-
-
Leunis, A.1
Blommestein, H.M.2
Huijgens, P.C.3
Blijlevens, N.M.4
Jongen-Lavrencic, M.5
Uyl-de Groot, C.A.6
-
21
-
-
84931586916
-
-
United Nations Development Programme Report. Human Development Report..
-
Malik, K. (2014) United Nations Development Programme Report. Human Development Report. http://hdr.undp.org/en/content/human-development-report-2014.
-
(2014)
-
-
Malik, K.1
-
22
-
-
33645498328
-
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
-
Mathews, V., George, B., Lakshmi, K.M., Viswabandya, A., Bajel, A., Balasubramanian, P., Shaji, R.V., Srivastava, V.M., Srivastava, A. & Chandy, M. (2006) Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood, 107, 2627-2632.
-
(2006)
Blood
, vol.107
, pp. 2627-2632
-
-
Mathews, V.1
George, B.2
Lakshmi, K.M.3
Viswabandya, A.4
Bajel, A.5
Balasubramanian, P.6
Shaji, R.V.7
Srivastava, V.M.8
Srivastava, A.9
Chandy, M.10
-
23
-
-
77956251955
-
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data
-
Mathews, V., George, B., Chendamarai, E., Lakshmi, K.M., Desire, S., Balasubramanian, P., Viswabandya, A., Thirugnanam, R., Abraham, A., Shaji, R.V., Srivastava, A. & Chandy, M. (2010) Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. Journal of Clinical Oncology, 28, 3866-3871.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 3866-3871
-
-
Mathews, V.1
George, B.2
Chendamarai, E.3
Lakshmi, K.M.4
Desire, S.5
Balasubramanian, P.6
Viswabandya, A.7
Thirugnanam, R.8
Abraham, A.9
Shaji, R.V.10
Srivastava, A.11
Chandy, M.12
-
24
-
-
84855457891
-
Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis
-
Parihar, M., Kumar, J.A., Sitaram, U., Balasubramanian, P., Abraham, A., Viswabandya, A., George, B., Mathews, V., Srivastava, A. & Srivastava, V.M. (2012) Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis. Leukaemia & Lymphoma, 53, 103-109.
-
(2012)
Leukaemia & Lymphoma
, vol.53
, pp. 103-109
-
-
Parihar, M.1
Kumar, J.A.2
Sitaram, U.3
Balasubramanian, P.4
Abraham, A.5
Viswabandya, A.6
George, B.7
Mathews, V.8
Srivastava, A.9
Srivastava, V.M.10
-
25
-
-
1842690785
-
Economic burden of acute myeloid leukemia: a literature review
-
Redaelli, A., Botteman, M.F., Stephens, J.M., Brandt, S. & Pashos, C.L. (2004) Economic burden of acute myeloid leukemia: a literature review. Cancer Treatment Reviews, 30, 237-247.
-
(2004)
Cancer Treatment Reviews
, vol.30
, pp. 237-247
-
-
Redaelli, A.1
Botteman, M.F.2
Stephens, J.M.3
Brandt, S.4
Pashos, C.L.5
-
26
-
-
0028051668
-
Costs over time in conventional treatment of acute myeloid leukaemia. A study exploring changes in treatment strategies over two decades
-
Stalfelt, A.M. & Brodin, H. (1994) Costs over time in conventional treatment of acute myeloid leukaemia. A study exploring changes in treatment strategies over two decades. Journal of Internal Medicine, 236, 401-409.
-
(1994)
Journal of Internal Medicine
, vol.236
, pp. 401-409
-
-
Stalfelt, A.M.1
Brodin, H.2
-
28
-
-
0035081928
-
Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the netherlands
-
Uyl-de Groot, C.A., Gelderblom-den Hartog, J., Huijgens, P.C., Willemze, R. & van Ineveld, B.M. (2001) Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the netherlands. J Hematother Stem Cell Res, 10, 187-192.
-
(2001)
J Hematother Stem Cell Res
, vol.10
, pp. 187-192
-
-
Uyl-de Groot, C.A.1
Gelderblom-den Hartog, J.2
Huijgens, P.C.3
Willemze, R.4
van Ineveld, B.M.5
-
29
-
-
84931586917
-
-
Wikipedia, List of countries by GNI (nominal, Atlas method) per capita..
-
Wikipedia (2014) List of countries by GNI (nominal, Atlas method) per capita. http://en.wikipedia.org/wiki/List_of_countries_by_GNI_(nominal, _Atlas_method)_per_capita.
-
(2014)
-
-
-
30
-
-
0035871889
-
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
-
Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. & Naoe, T. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434-2439.
-
(2001)
Blood
, vol.97
, pp. 2434-2439
-
-
Yamamoto, Y.1
Kiyoi, H.2
Nakano, Y.3
Suzuki, R.4
Kodera, Y.5
Miyawaki, S.6
Asou, N.7
Kuriyama, K.8
Yagasaki, F.9
Shimazaki, C.10
Akiyama, H.11
Saito, K.12
Nishimura, M.13
Motoji, T.14
Shinagawa, K.15
Takeshita, A.16
Saito, H.17
Ueda, R.18
Ohno, R.19
Naoe, T.20
more..
|